The results offer us a comprehensive understanding of the therapeutic effects of previously identified target proteins, including AKT1, IL6, PPARG, JUN, CASP3, EGFR, and PTGS2, in the context of diabetes intervention. This evidence concerns the gene EGFR and diabetes mellitus.